Home » Topics » BioWorld Science

BioWorld Science
RSS

Otsuka reports topline phase III results for centanafadine in adults with ADHD

June 12, 2020

Medicenna Therapeutics' IL-2 superkine MDNA-11 inhibits tumor growth

June 12, 2020

IFM Due discovers new hSTING antagonists

June 12, 2020

Xios Therapeutics synthesizes new adenosine A2A and A2B receptor antagonists

June 12, 2020

New HBV antivirals identified by Enanta Pharmaceuticals

June 12, 2020

Hinova Pharmaceuticals presents EP300 inhibitors

June 12, 2020

Nflection Therapeutics divulges new MAP2K1 inhibitors

June 12, 2020

USP48 found to be involved in hereditary hearing loss in animal model

June 12, 2020

ANGPT2 as novel diagnostic biomarker for primary lymphedema

June 12, 2020

Ausio Pharmaceuticals presents early clinical data for S-equol in TNBC

June 12, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.